BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31141116)

  • 1. Hyaluronidase Treatment of Scleroderma-Induced Microstomia.
    Melvin OG; Hunt KM; Jacobson ES
    JAMA Dermatol; 2019 Jul; 155(7):857-859. PubMed ID: 31141116
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyaluronidase as a Successful Treatment Modality for Scleroderma-Induced Microstomia.
    Chopra D; Brehm JE; Morrison B
    Dermatol Surg; 2022 Sep; 48(9):1014-1015. PubMed ID: 35834642
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyaluronidase Injections for Oral Microstomia in Systemic Sclerosis and Mixed Connective Tissue Disease.
    Min MS; Goldman N; Mazori DR; Guo LN; Vleugels RA; LaChance AH
    JAMA Dermatol; 2023 Dec; 159(12):1393-1395. PubMed ID: 37851438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Microstomia as a complication of scleroderma].
    Phoa KH; de Baat P; de Baat C
    Ned Tijdschr Tandheelkd; 2003 Nov; 110(11):457-9. PubMed ID: 14669488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of systemic scleroderma with high dosage of intravenous hyaluronidase].
    Petter O; Bellmann H
    Hautarzt; 1971 Jan; 22(1):32-3. PubMed ID: 4251354
    [No Abstract]   [Full Text] [Related]  

  • 6. A simplified technique for prosthetic treatment of microstomia in a patient with scleroderma: a case report.
    al-Hadi LA
    Quintessence Int; 1994 Aug; 25(8):531-3. PubMed ID: 7568699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of microstomia secondary to sclerodermatomyositis.
    Sanders B; McKelvy B; Cruickshank G
    J Oral Surg; 1977 Jan; 35(1):57-9. PubMed ID: 264260
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hyaluronidase therapy of progressive scleroderma].
    Mahrle G; Herrmann WP; Steigleder GK
    Hautarzt; 1972 Jul; 23(7):305-7. PubMed ID: 4655110
    [No Abstract]   [Full Text] [Related]  

  • 9. Small mouths ... Big problems? A review of scleroderma and its oral health implications.
    Albilia JB; Lam DK; Blanas N; Clokie CM; Sándor GK
    J Can Dent Assoc; 2007 Nov; 73(9):831-6. PubMed ID: 18028759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of the Current Medical and Surgical Treatment Options for Microstomia in Patients With Scleroderma.
    Gonzalez CD; Pamatmat JJ; Hutto JC; Goff HW
    Dermatol Surg; 2021 Jun; 47(6):780-784. PubMed ID: 33867466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facilitation of Prosthetic Rehabilitation in Scleroderma: Case History Report.
    Mostafavi AS; Hajimahmoudi M
    Int J Prosthodont; 2017; 30(4):396-397. PubMed ID: 28697214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nonsurgical treatment of microstomia in scleroderma: a pilot study.
    Naylor WP; Douglass CW; Mix E
    Oral Surg Oral Med Oral Pathol; 1984 May; 57(5):508-11. PubMed ID: 6587299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posterior Based Triangular Mucosal Advancement Flap for Surgical Correction of Scleroderma-Induced Microstomia.
    Kao TY; Kim TS; Alqussair A; Choi JY
    J Craniofac Surg; 2021 Jan-Feb 01; 32(1):e92-e94. PubMed ID: 33186280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prosthetic rehabilitation with collapsible hybrid acrylic resin and permanent silicone soft liner complete denture of a patient with scleroderma-induced microstomia.
    Singh K; Gupta N; Gupta R; Abrahm D
    J Prosthodont; 2014 Jul; 23(5):412-6. PubMed ID: 24417310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flexible, removable partial denture for a patient with systemic sclerosis (scleroderma) and microstomia: a clinical report and a three-year follow-up.
    Samet N; Tau S; Findler M; Susarla SM; Findler M
    Gen Dent; 2007; 55(6):548-51. PubMed ID: 18050582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral management of the scleroderma patient.
    Naylor WP
    J Am Dent Assoc; 1982 Nov; 105(5):814-7. PubMed ID: 6960074
    [No Abstract]   [Full Text] [Related]  

  • 17. Progressive systemic sclerosis--oro-facial manifestations. Case report.
    Wardrop RW; Heggie AA
    Aust Dent J; 1987 Aug; 32(4):258-62. PubMed ID: 3479964
    [No Abstract]   [Full Text] [Related]  

  • 18. Scleroderma and dentistry: every dentist is a scleroderma specialist.
    Leader DM
    J Mass Dent Soc; 2007; 56(2):16-9. PubMed ID: 17691504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prosthodontic management alternative for scleroderma patients.
    Yenisey M; Külünk T; Kurt S; Ural C
    J Oral Rehabil; 2005 Sep; 32(9):696-700. PubMed ID: 16102084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple and effective method for prosthetic rehabilitation in scleroderma patients: a clinical report.
    Hajimahmoudi M; Mostafavi AS
    Int J Prosthodont; 2014; 27(2):169-73. PubMed ID: 24596917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.